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Abstract Growth and progression of many cancer
cells are mediated by alterations in the microenviron-
ment often caused by an aberrant expression of growth
factors and receptors. There is no report on expression
of growth factor granulocyte colony-stimulating factor
(G-CSF) in the experimental model, colon adenocar-
cinoma cell line (Caco2), that is commonly used in
drug permeability assays. We hypothesize that in
vitro, the Caco2 model is associated with a constitu-
tive neo-expression of the hematopoietic G-CSF
thereby causing an autocrine stimulation of Caco2
growth and proliferation in vitro. To test our hypoth-
esis, we analyzed mRNA and protein expression of G-
CSF in Caco2 cells using reverse transcriptase-PCR
and SDS-PAGE. G-CSF mRNA and protein were
detected in Caco2 cells. Expression of G-CSF protein
was similar at different passages of this cell line. The
expression of G-CSF has a significant role in the
autocrine regulation of Caco2 cell growth and
proliferation.
Keywords Colon adenocarcinoma cells (Caco-2) 
Granulocyte colony-stimulating factor (G-CSF)  RT-
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Introduction
Cancer is often the result of an unregulated expression
of growth factors (Mueller et al. 1999) that stimulate
tumor cell proliferation and/or stromal activation and
angiogenesis through autocrine or paracrine loops
with the appropriate receptor-bearing cells (Mueller et
al. 2001). Among these aberrantly expressed factors
are the hematopoietic growth factors (Williams and
Quesenberry 1992), granulocyte colony-stimulating
factor (G-CSF) (Avalos et al. 1990) and granulocyte–
macrophage colony-stimulating factor (GM-CSF)
(Aaronson 1991). They were originally identified as
factors controlling proliferation, maturation, and
functional activity of granulocytes and macrophages
(Bussolino et al. 1989). The mature hG-CSF is a
18.7 kDa glycoprotein consisting of 174 amino acid
residues (Demetri and Griffin 1991). Beside its
function as growth and differentiation factors of the
hematopoietic system, G-CSF is also expressed by
fibroblasts (Moore 1991), endothelial cells (Kikuchi et
al. 1996), and keratinocytes (Mann et al. 2001). Both
factors are well established as inducers of endothelial
cell proliferation (Bocchietto et al. 1993) and migra-
tion in vitro and as stimulators of angiogenesis in vivo
(Thacker et al. 1994).
Recently, G-CSF has gained increasing attention as
factor that is aberrantly expressed in a number of
different solid tumors (Westphal et al. 2002) such as
squamous cell carcinomas (SCCs) of the esophagus and
tongue (Horii et al. 1997), and head and neck carcinomas
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(Tsukuda et al. 1993). Frequently, expression of G-CSF
by tumor cells is associated with co-expression of the
respective receptor, and there are indications that this
factor receptor co-expression may lead to an autocrine
stimulation of tumor cell growth, migration, invasion,
and metastasis (Mizuno et al. 1994). G-CSF stimulates
proliferation and migration of SCCs of the skin and
gliomas. Expression of G-CSF is associated with more
aggressive tumor growth in cervical cancer and enhanced
invasion (Ninci et al. 2000) and metastasis in head and
neck tumors (Mann et al. 1992). In addition to this
autocrine effect on the cytokine-producing tumor, G-
CSF may also act in a paracrine manner on the tumor-
surrounding stroma, e.g., by promoting an angiogenic
response (Natori et al. 2002).
Caco-2 cells are polarized epithelial cells. They can
form a differentiated monolayer that resembles the
human intestinal epithelium (Calatayud et al. 2002).
Profiles of the expression of the hG-CSF gene in Caco-
2 cells and in human intestine cells might be different.
Thus, we can hypothesize that G-CSF may contribute
to colon cancer progression not only by acting on the
colon carcinoma cells themselves but also by activat-
ing and/or modulating effects on the tumor stroma
and/or the entire organ. Although the mechanistic
basis of these modulating effects remains largely
unknown, the clinical relevance of G-CSF mediated
effects for patient prognosis becomes increasingly
manifest. To date there is no conclusive study on the
expression of G-CSF in human carcinoma cells or
Caco2 cells in culture. In this report, first time we have
demonstrated the expression of G-CSF in Caco2 cells
and also analyzed level of G-CSF expression at




Caco2 HTB37 cells were from ATCC. Culture flasks,
medium, chemicals and reagents were procured from
recognized commercial suppliers.
Caco-2 cell studies
All cultures were maintained in a humidified 37 C
incubator with a 5 % (v/v) CO2 in air. Complete
growth medium was prepared by adding 16 % (v/v)
heat-inactivated FBS to DMEM containing 25 mM
glucose and 4 mM L-glutamine and supplemented
with 0.1 mM non-essential amino acids, and sodium
penicillin G/streptomycin (100 U/ml). Caco-2 cells at
passages 32–58 were seeded at 2.5 9 105/cm2 on to
uncoated six well culture plates using complete
growth medium and grown for 3 weeks. After growth,
the medium was replaced and the culture was washed
with PBS buffer (pH 7.4). Cells were scraped into
20 mM Tris/HCl buffer (pH 8.0), and colony PCR was
used to amplify the G-CSF gene. The cells from the
remainder of the wells were scraped and homogenized
in a buffer [20 % (v/v) glycerol, 100 mM Tris/HCl,
pH 7.4, 10 mM EDTA, 1 mM dithiothreitol contain-
ing 1 mM PMSF, 1 mM benzamidine, and aprotinin
100 lg/ml]. These homogenates were subjected to
SDS-PAGE.
RNA isolation and RT-PCR for detection of
G-CSF expression in Caco-2 cells
Caco-2 cells were scraped from confluent growth in a
T 75 flask, pelleted at 2009g for 5 min and washed
with cold PBS. Total RNA was isolated using the
RNeasy Mini kit (Qiagen), following the manufac-
turer’s instructions except that RNA was eluted in
30 ll nuclease-free water. RT-PCR was carried out
using SuperScript First Strand Synthesis kit from
Invitrogen. Reverse transcription reaction was per-
formed in 20 ll, using 1 lg Caco-2 total RNA,
0.5 mmol dNTP mix (dATP, dGTP, dCTP, and
dTTP); 2.5 lM oligo dT primer and RNase-free H2O
in 10 ll. This RNA primer mixture was incubated at
65 C for 5 min followed by holding on ice for 1 min.
To this reaction mixture (9 ll), 80 units RNase OUT,
reverse transcription buffer, 1.25 mM MgCl2 and
10 mM DTT, in 10 ll, was added, incubated at 42 C
for 2 min and finally 1 ll (200 units/ll) SuperScript
III RT was added and kept at 50 C for 50 min. The
reaction was terminated at 95 C for 5 min followed
by addition of 2 units RNase H at 37 C for 20 min.
First strand cDNA, obtained in the synthesis reaction,
was used to amplify human G-CSF DNA. PCR
reaction mixture was prepared with 5 ll cDNA
template and 45 ll reaction mixture containing 5.5
units of Expand High fidelity polymerase (Roche,
Germany), reaction buffer, 0.3 mM dNTP, 0.3 pmol
forward and reverse-primers (synthesized by Sigma
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Aldrich, USA) each in 50 ll. Annealing temperature
was optimized by gradient PCR using 10 ll of PCR
reaction mixture at different annealing temperatures
ranging from 50, 55.5, 61.8, 66.8 and 70 C (DYAD
PCR machine from MJ research). PCR conditions for
G-CSF were as follows: initial denaturation 95 C for
5 min, 29 cycles of 95 C for 1 min, gradient of
annealing temperatures for 30 s, 72 C for 1 min and
final extension at 72 C for 10 min. Specific amplifi-
cation was obtained at 55.5 C annealing temperature.
The PCR amplification products were electrophoresed
in 1 % agarose gel and the bands were visualized after
staining with ethidium bromide and ultraviolet light
exposure. The gene sequence was confirmed by
sequencing.
Results and discussion
RT-PCR detects G-CSF mRNA expression in
Caco2 cells
Total RNA extracted from Caco2 cells of passage nos.
35–55 was subjected to RT-PCR using G-CSF specific
primers (Fig. 1). G-CSF mRNA expression was
detected in early culture passages and was maintained
in later passages as well (35 up to passage 55).
Threshold for detecting transcripts of G-CSF in
Caco2
Total RNA from different passages of Caco2 cells was
serially diluted to define the threshold quantity of total
RNA required to detect transcripts of G-CSF using
RT-PCR (Fig. 2). G-CSF mRNA transcripts were
detected using 0.5 lg RNA in the sample obtained
from different passages. These data demonstrate that
G-CSF amplicons obtained in RT-PCR reactions that
reflect the presence of G-CSF gene in Caco2 cells.
Sensitivity of RT-PCR for detecting G-CSF in
Caco2 cells
Caco2 human colon carcinoma cells were serially
diluted with Tris/HCl buffer (pH 7.4) as outlined in
Fig. 3. Total RNA extracted from these samples
Fig. 1 RT-PCR of G-CSF gene expression in colon adenocar-
cinoma (Caco2) cells. RT-PCR was performed using G-CSF
specific primers. Total RNA was isolated from various passages.
Total extracted RNA (2 lg) was reverse-transcribed and a
portion (1/10) was subjected to PCR for the specific amplifica-
tion of G-CSF gene. The reaction mixtures were separated on a
1.5 % agarose gel and visualized by ethidium bromide (EtBr).
Lane 1 passage no. 35; Lane 2 passage no. 40; Lane 3 passage
no. 45; Lane 4 passage no. 50; Lane 5 passage no. 55; Lane 6
100 bp DNA ladder
Fig. 2 Threshold for detecting G-CSF mRNA in Caco2 cells.
Total RNA from Caco2 cells was isolated and subjected to RT-
PCR using G-CSF specific primers. Lane 1, negative control
(NC, H2O); Lane 2 0.5 lg; Lane 3 1.0 lg; Lane 4 1.5 lg; Lane 5
marker lane (M, 100 bp DNA ladder)
Fig. 3 Sensitivity of RT-PCR using G-CSF specific primers for
detecting G-CSF mRNA expression in Caco2 cells. Total RNA
(0.5 lg) extracted from the indicated number of Caco2 cells and
subjected to RT-PCR. Lane 1 no cells (NC); Lane 2 107 cells;
Lane 3 106 cells; Lane 4 105 cells; Lane 5 104 cells; Lane 6
marker lane (M, 100 bp DNA ladder)
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(0.5 lg) was subjected to RT-PCR employing G-CSF
specific primers. G-CSF mRNA from Caco2 cell was
detected in 1000-fold diluted cells. This level of
sensitivity for detecting human G-CSF mRNA in
Caco2 cells was highly reproducible and yielded
identical results in duplicate.
Expression of G-CSF at the protein level
Under general culture conditions, Caco2 cells were
cultured in DMEM medium for 5 days, and the G-CSF
protein was detected by performing SDS-PAGE anal-
ysis of the crude cell lysates (Fig. 4a). One of the bands,
~19 kDa, was visualized by Coomassie Blue staining.
The identity of the G-CSF protein was further con-
firmed by using anti-human G-CSF monoclonal anti-
body by western blotting as illustrated in Fig. 4b.
Detectable amounts of G-CSF protein could be mon-
itored using a commercial ELISA kit with Caco2 cells
at various passages (35–55) as outlined in Table 1. The
expression of G-CSF protein did not change apprecia-
bly with increasing passages (Fig. 4a).
The present study demonstrates that G-CSF mRNA
is expressed at detectable levels in Caco2 cells.
Expression of this transcript and G-CSF protein in
Caco2 cells could be a potential explanation for the
risk of colon cancer. The sensitivity of RT-PCR assay
is sufficient to detect G-CSF mRNA transcripts in
1000-fold diluted Caco2 cells and the results are
reproducible. These data suggest that G-CSF mRNA
expression could be used as a tool in early detection of
colorectal cancer.
In this study, Caco2 cells expressed significant
amounts of G-CSF (Table 1) and the expression level
was constant irrespective of passages (35 up to 55).
There was a positive correlation between the mRNA
and protein level of G-CSF in Caco2 cells. G-CSF is
one of the human cytokines exhibiting a variable
pattern of its expression across the organs and tissues.
It is expressed to the brush border membranes of
intestinal mucosa cells from the duodenum to the
rectum (Toribara and Sleisenger 1995). Of signifi-
cance, G-CSF continues to be expressed in intestinal
mucosal cells after they have undergone neoplastic
transformation. G-CSF expression has been detected
in all primary and metastatic colorectal tumors
including those originating from poorly differentiated
colorectal tumors (Yang et al. 2005). This restricted
Fig. 4 Analysis of soluble fraction of Caco2 cell crude extract
by SDS–PAGE and western blot. a SDS–PAGE gel stained with
Coomassie Blue. 20 lg of the crude cell extract was loaded in
each lane. Lane 1 passage no. 35; Lane 2 passage no. 40; Lane 3
passage no. 45; Lane 4 passage no. 50; Lane 5 passage no. 55;
Lane 6, protein molecular mass markers. b Western blot analysis
of G-CSF protein in crude extract of Caco2 cells. Crude G-CSF
protein was transferred to a nitrocellulose membrane after 12 %
SDS-PAGE. The membrane was incubated in 3 % (w/v) BSA
and then incubated in 1:2,000 dilution of monoclonal mouse
anti-GCSF antibody in the blocking buffer. After washing, the
membrane was incubated in 1:10,000 dilution of horse-radish
peroxidase-conjugated sheep anti-mouse IgG in the blocking
buffer. Antibody bound protein was detected with chemilumi-
nescent substrate (SuperSignal, Pierce). Arrows show the G-
CSF protein (19 kDa) and the immuno band, respectively
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pattern of G-CSF and its receptor expression may be a
useful biomarker for metastatic colorectal cancer cells
in intestinal and extra intestinal sites. Similarly,
analyzing G-CSF expression in colon cancer could
improve the early detection of disease in patients.
In summary, for the first time G-CSF has been
constitutively expressed in Caco2 cells. Our findings
indicate that the expression of G-CSF might play an
important role in differentiation and proliferation
during growth of Caco-2 culture and may involve in
the progression of colon adenocarcinoma in human
as well. As a result, G-CSF may be a more sensitive
and specific biomarker for detection of metastatic
colorectal cancer cells. Further study comparing
expression of G-CSF in normal and colon carcinoma
patients is warranted to prove the application of this
biomarker.
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